Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
barasertib-HQPA (AZD2811)
i
Other names:
AZD2811, AZD 1152 hQPA, AZD 2811
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
AstraZeneca, Pfizer
Drug class:
Aurora kinase B inhibitor
Related drugs:
‹
HI-511 (1)
NMI-900 (1)
AZD1152 (1)
CS 2164 (1)
AT9283 (0)
BI 847325 (0)
EP0042 (0)
ZM 447439 (0)
SKI-G-801 (0)
HI-511 (1)
NMI-900 (1)
AZD1152 (1)
CS 2164 (1)
AT9283 (0)
BI 847325 (0)
EP0042 (0)
ZM 447439 (0)
SKI-G-801 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
BCL2 overexpression
Non Small Cell Lung Cancer
BCL2 overexpression
Non Small Cell Lung Cancer
AZD2811
Resistant: D – Preclinical
AZD2811
Resistant
:
D
AZD2811
Resistant: D – Preclinical
AZD2811
Resistant
:
D
CDH1 overexpression
Small Cell Lung Cancer
CDH1 overexpression
Small Cell Lung Cancer
AZD2811
Resistant: D – Preclinical
AZD2811
Resistant
:
D
AZD2811
Resistant: D – Preclinical
AZD2811
Resistant
:
D
MYC expression
Small Cell Lung Cancer
MYC expression
Small Cell Lung Cancer
AZD2811
Sensitive: D – Preclinical
AZD2811
Sensitive
:
D
AZD2811
Sensitive: D – Preclinical
AZD2811
Sensitive
:
D
VIM expression
Small Cell Lung Cancer
VIM expression
Small Cell Lung Cancer
AZD2811
Sensitive: D – Preclinical
AZD2811
Sensitive
:
D
AZD2811
Sensitive: D – Preclinical
AZD2811
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login